Google DeepMind releases AlphaGenome 2 for cell-specific disease research
Cell-specific variant interpretation is a bottleneck in translating genome sequencing into clinical insight, and AlphaGenome 2 targets exactly that gap. Genomics labs, computational biologists, and biotech teams evaluating disease-causing mutations can use it to prioritise variants by affected tissue. Compared with AlphaFold, which resolved protein structure, this model moves DeepMind's tooling upstream into gene regulation, a space where competitors like Enformer and Evotec partnerships have been active.
Google DeepMind announced AlphaGenome 2, a new AI model designed to help scientists understand how genetic variants drive disease in specific cell types. The model addresses a core puzzle in genomics: heart, brain, and immune cells all carry the same DNA sequence, yet a single-letter change can cause disease in one cell type while leaving others unaffected.
AlphaGenome 2 zooms in on particular cells to interpret how variants affect gene regulation in their specific context, rather than treating the genome as a uniform sequence. This cell-specific lens allows researchers to trace how the same mutation produces different effects across tissues, pointing toward the regulatory mechanisms behind complex diseases.
The release builds on DeepMind's line of biology models following AlphaFold, extending AI from protein structure prediction into genome interpretation. For researchers studying rare variants of uncertain significance, the tool offers a way to prioritise which mutations are likely functional and in which tissues, a step relevant to diagnostics and drug target selection.
Your heart, brain, and immune system share the same DNA sequence. So how can a single-letter change affect disease in some cells, while sparing the rest? AlphaGenome 2 is our new AI model that zooms in on specific cells to help scientists understand what drives disease. 🧵
This report is categorized under AITOP's "Products" desk, focusing on US frontier AI labs and Silicon Valley technology leaders. Within our cross-regional analytical framework, it directly maps to AI developer toolchains, coding agents, and engineering workflows and US-China foundation model benchmarks and commercialization comparison. Key entities and technical topics under continuous tracking include AlphaGenome, Google DeepMind, genomics, variant interpretation.
Source attribution: curated from Google DeepMind (@GoogleDeepMind).
